Immunogen, Inc. (IMGN) Tops Q4 Expectations
Immunogen, Inc.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
(NASDAQ: IMGN) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $3.44 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.